Differential mechanism of the effects of ester-type local anesthetics on sarcoplasmic reticulum Ca-ATPase.
The effect of the local anesthetics procaine and tetracaine on sarcoplasmic reticulum membranes isolated from two masticatory muscles, masseter and medial pterygoid, was tested and compared to fast-twitch muscles. The effects of the anesthetics on Ca-ATPase activity, calcium binding, uptake, and phosphorylation of the enzyme by inorganic phosphate (Pi) were tested with radioisotopic methods. Calcium binding to the Ca-ATPase was non-competitively inhibited, and the enzymatic activity decreased in a concentration-dependent manner. The inhibition of the activity depended on pH, calcium concentration, the presence of the calcium ionophore calcimycin, and the membrane protein concentration. Unlike fast-twitch membranes, the pre-exposure of the masseter and medial pterygoid membranes to the anesthetics enhanced the enzymatic activity in the absence of calcimycin, supporting their permeabilizing effect. Procaine and tetracaine also interfered with the calcium transport capability, decreasing the maximal uptake without modification of the calcium affinity for the ATPase. Besides, the anesthetics inhibited the phosphorylation of the enzyme by Pi in a competitive manner. Tetracaine revealed a higher inhibitory potency on Ca-ATPase compared to procaine, and the inhibitory concentrations were lower than usual clinical doses. It is concluded that procaine and tetracaine not only affect key steps of the Ca-ATPase enzymatic cycle but also exert an indirect effect on membrane permeability to calcium and suggest that the consequent myoplasmic calcium increase induced by the anesthetics might account for myotoxic effects, such as sustained contraction and eventual rigidity of both fast-twitch and masticatory muscles.
Biophysics Department, School of Dentistry, University of Buenos Aires, M T de Alvear 2142, 17th Floor B, Buenos Aires, 1122AAH, Argentina, gabriel@odon.uba.ar.
G A
GA
Sánchez
D E
DE
Di Croce
C
C
de la Cal
S B
SB
Richard
D
D
Takara
D000779:Anesthetics, Local / Q000494:pharmacology*; D000818:Animals; D002118:Calcium / Q000378:metabolism; D061207:Calcium Ionophores / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D004952:Esters / Q000494:pharmacology*; D006863:Hydrogen-Ion Concentration; D008297:Male; D008410:Masticatory Muscles / Q000187:drug effects* / Q000201:enzymology; D018656:Muscle Fibers, Fast-Twitch / Q000187:drug effects* / Q000201:enzymology; D010766:Phosphorylation; D011343:Procaine / Q000494:pharmacology*; D011817:Rabbits; D012519:Sarcoplasmic Reticulum / Q000187:drug effects* / Q000201:enzymology; D053498:Sarcoplasmic Reticulum Calcium-Transporting ATPases / Q000037:antagonists & inhibitors* / Q000378:metabolism; D013748:Tetracaine / Q000494:pharmacology*; D013997:Time Factors
D000779:Anesthetics, Local; D061207:Calcium Ionophores; D004791:Enzyme Inhibitors; D004952:Esters; D013748:Tetracaine; D011343:Procaine; D053498:Sarcoplasmic Reticulum Calcium-Transporting ATPases; D002118:Calcium